Company intelligence / Profile preview
Good Cells
Yongin-si, Gyeonggi-do, South Koreagoodcells.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Good Cells is a South Korean biotechnology company specializing in the development of advanced cell therapies for oncology and regenerative medicine. The company leverages a proprietary platform for the high-purity expansion and activation of Natural Killer (NK) cells to target various solid tumors. Additionally, Good Cells develops mesenchymal stem cell (MSC) therapies aimed at treating inflammatory and autoimmune conditions such as atopic dermatitis and osteoarthritis. By integrating cutting-edge cell engineering with clinical research, the company seeks to provide next-generation treatments for diseases with high unmet medical needs.
- Therapeutic areas
- RheumatologyDermatologyImmunologyOncology
- Modalities
- NK cell therapyStem cell therapyCell therapyBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Good Cells.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Good Cells.